Companies / InspireMD, Inc.

InspireMD, Inc.

Nasdaq: NSPRCIK 1433607MIAMI, FL

Financials · FY2025

Revenue$8.98M
Net income$-48.79M
Total debt$5.01M
Cash$11.36M
Diluted EPS$-0.76
Shares outstanding46.8M

Ownership

46.8M shares outstanding · as of May 7, 2026
10.5%Insiders
Ownership
Insiders10.52%4,927,589
10%+ / strategic6.78%3,173,364
Institutions42.75%20,025,882
Public float39.95%18,712,127

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 10

View all →
Insider% of sharesShares
Gleason Shane ThomasChief Commercial Officer
2.43%1,139,177
Tommasoli AndreaChief Operating Officer
2.04%954,389
Roubin Gary SDirector
1.78%834,478
Lawless Michael AChief Financial Officer
1.48%691,695
Stuka PaulDirector
1.12%523,704
Berman MichaelDirector
0.75%352,586
Ward Scott R.Director
0.51%237,096
Dearen Danny L.Director
0.22%102,047
Cohen Raymond WDirector
0.20%92,417
Slosman MarvinCEOCEO and President · Director
——

Institutional holders 46

View all →
HolderValue% of shares
Rosalind Advisors, Inc.$6.95M8.34%
Nantahala Capital Management, LLC$6.01M7.21%
Aberdeen Group plc$5.65M6.78%
Orbimed Advisors LLC$5.11M6.69%
Parkman Healthcare Partners LLC$4.30M5.16%
Velan Capital Investment Management LP$3.82M4.58%
Marshall Wace, LLP$3.03M3.97%
Soleus Capital Management, L.P.$2.05M2.46%
Pura Vida Investments, LLC$801.9K0.96%
Affiance Financial, LLC$445.7K0.53%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
May 7, 2026Roubin Gary S
Director
BuyCommon Stock$106.2K+90K
+12.09%
834,478
1.78% of shares
medium
May 7, 2026Ward Scott R.
Director
BuyCommon Stock$84.2K+73K
+44.71%
237,096
0.51% of shares
medium
Jan 21, 2026Gleason Shane Thomas
Executive
SellCommon Stock$28.6K-18K
-1.48%
1,174,664
2.51% of shares
low
Jan 28, 2026Gleason Shane Thomas
Executive
SellCommon Stock$20.5K-12K
-1.07%
1,149,077
2.45% of shares
low
May 6, 2026Ward Scott R.
Director
BuyCommon Stock$18.4K+16K
+10.82%
163,841
0.35% of shares
low
Jan 22, 2026Gleason Shane Thomas
Executive
SellCommon Stock$13.2K-8K
-0.72%
1,166,253
2.49% of shares
low
Jan 29, 2026Gleason Shane Thomas
Executive
SellCommon Stock$8.3K-5K
-0.44%
1,144,077
2.44% of shares
low
Jan 27, 2026Gleason Shane Thomas
Executive
SellCommon Stock$8.0K-5K
-0.41%
1,161,472
2.48% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Orbimed Advisors LLCPassive13G———
Aberdeen Group plcPassive13G/A—3,173,364—
Rosalind Advisors, Inc.Passive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
NSPRCommon StockEquity45779A846BBG000QDM9D4